Precipio (PRPO) reported third-quarter 2026 revenue of $7.3 million, up 8% from $6.8 million in the prior-year quarter and above $7.0 million in the second quarter of 2026. GAAP net income was $0.0 million for the quarter ended September 30, 2026.
The specialty cancer diagnostics company reported $0.4 million in adjusted EBITDA and $0.6 million in operating cash flow during the quarter. Total cash increased by $0.5 million to more than $3.5 million at quarter-end.
- Product revenue was $1.0 million, up 40% year over year.
- Pathology revenue was $6.3 million, up 5% year over year.
- Adjusted EBITDA was $0.4 million, compared with $0.5 million in Q3 2025.
- Cash flow from operations was $0.6 million in Q3 2026.
$PRPO Insider Trading Activity
$PRPO insiders have traded $PRPO stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PRPO stock by insiders over the last 6 months:
- RICHARD A SANDBERG sold 900 shares for an estimated $22,517
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$PRPO Hedge Fund Activity
We have seen 5 institutional investors add shares of $PRPO stock to their portfolio, and 7 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TOPLINE CAPITAL MANAGEMENT, LLC removed 24,624 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $609,690
- UBS GROUP AG added 9,586 shares (+2794.8%) to their portfolio in Q3 2026, for an estimated $226,996
- EVERNEST FINANCIAL ADVISORS, LLC removed 9,500 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $235,220
- XTX TOPCO LTD added 9,450 shares (+inf%) to their portfolio in Q2 2026, for an estimated $233,982
- DIMENSIONAL FUND ADVISORS LP removed 8,396 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $198,817
- BLACKROCK, INC. added 5,633 shares (+19.4%) to their portfolio in Q2 2026, for an estimated $139,473
- RENAISSANCE TECHNOLOGIES LLC removed 3,101 shares (-16.1%) from their portfolio in Q2 2026, for an estimated $76,780
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
